Home > Financial Ratios > ORCHID PHARMA

ORCHID PHARMA
EV/EBIT

    Back to All Ratios
AD     Remove this Ad

ORCHID PHARMA Last 5 Year EV/EBIT History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/EBIT(x) 35.6147.5621.21-60.59-243.82

What is the latest EV/EBIT ratio of ORCHID PHARMA ?

The latest EV/EBIT ratio of ORCHID PHARMA is 35.61 based on Mar2025 Consolidated results.
Year EV/EBIT
Mar202535.61
Mar202447.56
Mar202321.21
Mar2022-60.59
Mar2021-243.82

How is EV/EBIT of ORCHID PHARMA Trending?

Years EV/EBIT % Change
Mar2025 35.61
-25.13
Mar2024 47.56
124.23
Mar2023 21.21
Positive
Mar2022 -60.59
Negative
Mar2021 -243.82 -

Other Financial Ratios of ORCHID PHARMA


Compare EV/EBIT ratio of peers of ORCHID PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
ORCHID PHARMA ₹3,418.2 Cr -3.1% -14.8% -48.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹390,828.0 Cr 1.2% -5.3% -5.6% Stock Analytics
DIVIS LABORATORIES ₹158,227.0 Cr -3.9% -6% 11.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹135,045.0 Cr 0.9% 3.7% 20.5% Stock Analytics
CIPLA ₹105,961.0 Cr -1.2% -12.6% -6.6% Stock Analytics
DR REDDYS LABORATORIES ₹98,682.5 Cr -3.4% -5.7% 0.3% Stock Analytics


ORCHID PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
ORCHID PHARMA

-3.1%

-14.8%

-48.4%

SENSEX

-0.2%

-4.2%

8.4%


You may also like the below Video Courses